PCM
LEGN icon

Penserra Capital Management’s Legend Biotech LEGN Stock Holding History

Penserra Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-720
Closed -$36K – 1464
2021
Q3 		$36K Buy
720
+150
+26% +$6.24K ﹤0.01% 1144
2021
Q2 		$23K Buy
570
+30
+6% +$1.02K ﹤0.01% 1123
2021
Q1 		$15K Buy
540
+50
+10% +$1.36K ﹤0.01% 995
2020
Q4 		$13K Buy
+490
New +$14.1K ﹤0.01% 900

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Penserra Capital Management's LEGN Position: Q4 2021 in Review

Penserra Capital Management sold out of Legend Biotech (LEGN) in Q4 2021, closing a stake of 720 shares — an estimated $36K sold.

Penserra Capital Management first reported a position in LEGN in Q4 2020 and held it in 4 quarters. The position peaked at $36K in Q3 2021. 139 funds tracked by Wall St. Rank hold LEGN as of Q4 2021.

  • Penserra Capital Management reported no remaining Legend Biotech position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 720 Legend Biotech shares in Q4 2021, an estimated $36K.
  • Penserra Capital Management first reported a position in Legend Biotech in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's Legend Biotech position peaked at $36K in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.